RecruitingNCT03470467

Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients


Sponsor

Ictal Group

Enrollment

300 participants

Start Date

Mar 9, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • age \>= 18 years
  • Posterior Reversible Encephalopathy Syndrome defined as:
  • combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea/vomiting, and focal neurological signs AND
  • cerebral imaging abnormalities involving the white matter (brain CT scan hypodensities AND/OR Brain MRI hypoT1, hyper T2 FLAIR)
  • intensive care unit admission

Exclusion Criteria1

  • normal cerebral imaging

Interventions

OTHERNo intervention

No intervention planed


Locations(1)

Intensive Care Unit - Versailles Hospital

Le Chesnay, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03470467